Live Breaking News & Updates on சுப்ரமணியம் வங்காள
Stay updated with breaking news from சுப்ரமணியம் வங்காள. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Anti-diabetic drug can be re-purposed as Covid treatment: Study Sat, Jul 03 2021 10:09:13 AM Hyderabad, Jul 3 (IANS): Amid the rush to develop cures for the coronavirus, a study by a University of Hyderabad (UoH) incubated startup, has discovered that an anti-diabetic drug has potential use as a ready to use, cost-effective solution for safely treating Covid patients. In-vitro and in-silico studies conducted by ReaGene Innovations Private Limited, a startup company incubated at the ASPIRE-BioNEST, and INDRAS Private Limited, indicate that re-purposing the anti-diabetic drug Ertugliflozin, might provide a therapeutic solution to the Covid-19 infection. Ertugliflozin, an FDA-approved drug for type-2 diabetes, works as SGLT-2 inhibitor by removing excessive glucose through urine. ....
Anti-diabetic drug can be re-purposed as Covid treatment: Study prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
Anti-diabetic drug promises therapeutic solution to COVID-19 infection thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Anti-diabetic drug promises therapeutic solution to COVID thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Anti-Diabetic Drug Can Be Repurposed For Safe, Cost-Effective Treatment Of COVID-19, Finds Study swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.